http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-108264465-B
Outgoing Links
| Predicate | Object |
|---|---|
| classificationCPCAdditional | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07B2200-13 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07C217-48 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07C213-08 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C217-48 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C213-08 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P15-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-138 |
| filingDate | 2017-12-21-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2020-08-11-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 2020-08-11-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | CN-108264465-B |
| titleOfInvention | Dapoxetine hydrochloride monohydrate, preparation method and application thereof |
| abstract | The invention discloses dapoxetine hydrochloride monohydrate, a preparation method thereof, a composition containing the hydrate, and application of the composition in preparation of a medicament for treating sexual dysfunction, wherein the dapoxetine hydrochloride monohydrate is shown as a formula I. The hydrate overcomes the defects of easy moisture absorption, poor stability, high requirement on storage conditions and unfavorable long-term storage of the existing crystal form or amorphous form of dapoxetine hydrochloride, and is more suitable for industrial amplification and preparation production. |
| priorityDate | 2016-12-30-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 109.